• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    NeuClone Announces Positive Results from Phase I Study of Stelara® (ustekinumab)

    BUSINESSWIRE

    NeuClone Discloses Two Biosimilars Referencing Opdivo® and Keytruda®

    BUSINESSWIRE

    NeuClone Announces Completion of Subject Visits in Stelara® (ustekinumab

    BUSINESSWIRE

    NeuClone Announces Completion of Subject Visits in Stelara® (ustekinumab)

    BUSINESSWIRE

    ​NeuClone Completes Dosing in Phase I Clinical Trial of Stelara

    BUSINESS WIRE

    NeuClone Announces Positive Results from Phase I Study of Herceptin

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.